Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001583098-25-000005
Filing Date
2025-11-12
Accepted
2025-11-12 16:13:07
Documents
1
Period of Report
2025-11-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1762981979.html 4  
1 FORM 4 wk-form4_1762981979.xml 4 3770
  Complete submission text file 0001583098-25-000005.txt   5214
Mailing Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879
Business Address 300 PROFESSIONAL DR GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O EMERGENT BIOSOLUTIONS INC. 300 PROFESSIONAL DRIVE GAITHERSBURG MD 20879
Business Address
DeGolyer Donald W (Reporting) CIK: 0001583098 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33137 | Film No.: 251472864